Abnormal bone turnover in long-standing Crohn's disease in remission

Alimentary Pharmacology and Therapeutics

Volumn 15, Issue 6, 2001, Pages 783-792

  Schoon, E J ^a   Geerling, B G ^a   Van Dooren, I M A ^a   Schurgers, L J ^b   Vermeer, C ^b   Brummer, R J M ^a   Stockbrugger R W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; OSTEOCALCIN;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM EXCRETION; CHRONIC DISEASE; CLINICAL ARTICLE; CROHN DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; MALE; MENOPAUSE; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; REMISSION;

ADULT; ALKALINE PHOSPHATASE; BONE DENSITY; BONE RESORPTION; CROHN DISEASE; DENSITOMETRY, X-RAY; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOGENESIS;

EID: 0034990684     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2001.00997.x     Document Type: Article

References (47)

1. Metabolic bone assessment in patients with inflammatory bowel disease
2. Osteoporosis in patients with inflammatory bowel disease
3. Low bone mineral density in patients with inflammatory bowel disease
4. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation
5. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel disease (Crohn's disease and ulcerative colitis)
6. Inflammatory bowel disease and osteoporosis
7. Osteoporosis: Prevention, diagnosis, and management
8. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study
9. The value of biochemical markers of bone turnover in osteoporosis
10. Altered bone metabolism in inflammatory bowel disease
11. Reduced bone density in patients with inflammatory bowel disease
12. Increased degradation of type I collagen in patients with inflammatory bowel disease
13. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease
14. Bone turnover during short-term therapy with methylprednisolone or budesonide in Crohn's disease
15. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease
16. Altered bone metabolism in inflammatory bowel disease: There is a difference between Crohn's disease and ulcerative colitis
17. Evolution of osteopenia in inflammatory bowel disease
18. Bone loss in patients with inflammatory bowel disease: A prospective study
19. Bone mineral density in patients with recently diagnosed inflammatory bowel disease
20. Bone density and calcium metabolism in patients with long-standing quiescent Crohn's disease
21. Increased bone resorption in patients with Crohn's disease
22. Alterations in bone metabolism in children with inflammatory bowel disease: An in vitro study
23. Classification of inflammatory bowel disease
24. Development of a Crohn's disease activity index
25. A short questionnaire for the measurement of habitual physical activity in epidemiological studies
26. Assessment of the serum levels of bone alkaline phosphatase with a new immunoradiometric assay in patients with metabolic bone disease
27. Immunoassay for quantifying type I collagen degradation products in urine evaluated
28. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment
29. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption
30. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer
31. Dual-energy X-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition
32. Spine and femur density using dual-photon absorptiometry in US white women
33. Determinants of bone density in normal women: Risk factors for future osteoporosis?
34. Dual-energy X-ray absorptiometry in normal women: A cross-sectional study of 717 Finnish volunteers
35. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis
36. Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease
37. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study
38. Relationship of bone turnover to bone density and fractures
39. Drug therapy for vertebral fractures in osteoporosis: Evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy
40. Are biochemical markers for bone turnover clinically useful for monitoring therapy in individual osteoporotic patients?
41. Osteoblast programmed cell death (apoptosis): Modulation by growth factors and cytokines
42. New developments in the pathogenesis and treatment of steroid-induced osteoporosis
43. Rapid spinal trabecular bone loss in female patients with ileitis terminalis Crohn and additional sacroiliac joint inflammation
44. Increase of bone mineral density with sodium fluoride in patients with Crohn's disease
45. Fluoride in osteoporosis: Still an experimental and controversial treatment
46. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
47. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease